COVAX says negotiating with new COVID-19 vaccine suppliers, scaling up

FILE PHOTO: A pack of AstraZeneca/Oxford vaccines is seen as the country receives its first batch o
FILE PHOTO: A pack of AstraZeneca/Oxford vaccines is seen as the country receives its first batch of coronavirus disease (COVID-19) vaccines under COVAX scheme, at the international airtport of Accra, Ghana February 24, 2021. REUTERS/Francis Kokoroko

GENEVA: The COVAX dose-sharing facility expects to have 1.9 billion doses of COVID-19 vaccines available by year-end, including 1.5 billion earmarked for the poorest countries, its managing director Aurelia Nguyen said on Tuesday (Jul 6).

The GAVI vaccine alliance, which runs COVAX with the World Health Organization, expects a "very strong increase in COVID-19 vaccine availability" towards the fourth quarter, she said.

COVAX, which has distributed some 95 million doses to 134 countries since late February, is diversifying its portfolio and is negotiating with new suppliers, she said.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters